Immune Correlate-Guided HIV Vaccine Design

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Designing an effective human immunodeficiency virus (HIV) vaccine presents significant scientific challenges despite successes with other pathogens.
• Research into correlates of protective immunity from human and non-human primate studies informs vaccine design strategies.
• Two primary approaches have emerged: inducing neutralizing antibodies and eliciting non-neutralizing, polyfunctional antibodies.

Purpose of the Study:

• To review current distinct vaccine design strategies for human immunodeficiency virus (HIV).
• To explore the potential for combining different immunological approaches for enhanced vaccine efficacy.
• To discuss the future direction for developing a globally protective HIV vaccine.

Main Methods:

• Review of existing scientific literature on HIV vaccine research.
• Analysis of two distinct vaccine design strategies focusing on different immune responses.
• Synthesis of findings to propose a convergent approach for future vaccine development.

Main Results:

• One strategy focuses on structure-based design of HIV envelope immunogens to induce neutralizing antibodies.
• A second strategy aims to generate non-neutralizing polyclonal and polyfunctional antibodies for viral clearance.
• Both strategies target different arms of the immune system to combat HIV.

Conclusions:

• Neither current strategy alone has proven sufficient for a globally protective HIV vaccine.
• The convergence of structure-based immunogen design and strategies for non-neutralizing antibodies is likely essential.
• A combined approach holds the most promise for the development of an effective and globally applicable HIV vaccine.